UPC covid caseload grows as Pfizer faces fresh action by EnantaAlready have access? Get news, unique commentary, expert analysis and essential resources from the IAM experts. Register to receive our newsletter and gain limited access to subscriber content. US biotech Enanta Pharmaceuticals has taken its enforcement campaign to the pan-EU court while appealing a US lossAccess more UPC dataFor a limited time, IAM is offering subscribers an extended free trial to our latest tool, which enables efficient access to UPC proceedings and valuable competitive intelligence.